BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19372827)

  • 1. Probing the possibilities for T-cell-based AIDS vaccines.
    Garber DA; Feinberg MB
    Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus.
    Friedrich TC; Watkins DI
    Curr Opin HIV AIDS; 2008 May; 3(3):393-8. PubMed ID: 19372996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise and challenge of anti-HIV cellular immunity.
    Borrow P; Turnbull EL
    Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccines: can mucosal CD4 T cells be protected?
    Mattapallil JJ; Roederer M
    Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of antibody-mediated protection against HIV infection.
    Sattentau Q
    Curr Opin HIV AIDS; 2008 May; 3(3):368-74. PubMed ID: 19372992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical studies of experimental vaccines.
    Bart PA; Harari A; Pantaleo G
    Curr Opin HIV AIDS; 2006 Jul; 1(4):286-93. PubMed ID: 19372823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype and function of protective T cell immune responses in HIV.
    Betts MR; Harari A
    Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical primate studies of HIV-1-envelope-based vaccines: towards human clinical trials.
    Heeney JL
    Curr Opin HIV AIDS; 2006 Jul; 1(4):336-43. PubMed ID: 19372830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses in primary HIV-1 infection.
    Frost SD; Trkola A; Günthard HF; Richman DD
    Curr Opin HIV AIDS; 2008 Jan; 3(1):45-51. PubMed ID: 19372943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell responses in primary HIV-1 infection.
    Streeck H; van Bockel D; Kelleher A
    Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal innate immunity as a determinant of HIV susceptibility.
    Iqbal SM; Kaul R
    Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral reservoirs and HIV-specific immunity.
    Blankson JN
    Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in clinical trials of vaccines to prevent HIV/AIDS.
    Fast PE
    Curr Opin HIV AIDS; 2006 Jul; 1(4):267-71. PubMed ID: 19372820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing developing countries for efficacy trials.
    Gray GE; de Bruyn G; Slack C; Steel G; Williamson C
    Curr Opin HIV AIDS; 2006 Jul; 1(4):330-5. PubMed ID: 19372829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.